The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

Ruth Ann Marrie, Stephen Reingold, Jeffrey Cohen, Olaf Stuve, Maria Trojano, Per Soelberg Sorensen, Gary Cutter, Nadia Reider

Research output: Contribution to journalArticle

168 Citations (Scopus)

Abstract

Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. Methods: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I2 statistic, and conducted meta-analyses. Results: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%10.3%) for psychosis. Conclusion: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.

Original languageEnglish (US)
Pages (from-to)305-317
Number of pages13
JournalMultiple Sclerosis
Volume21
Issue number3
DOIs
StatePublished - Mar 16 2015

Fingerprint

Multiple Sclerosis
Psychiatry
Comorbidity
Incidence
Anxiety
Depression
Age Factors
Bipolar Disorder
PubMed
Psychotic Disorders
Population
Alcoholism
Substance-Related Disorders
Fatigue
Meta-Analysis
Cross-Sectional Studies
Quality of Life
Databases
Therapeutics

Keywords

  • anxiety
  • bipolar disorder
  • comorbidity
  • depression
  • incidence
  • Multiple sclerosis
  • prevalence
  • psychosis
  • systematic review

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., ... Reider, N. (2015). The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review. Multiple Sclerosis, 21(3), 305-317. https://doi.org/10.1177/1352458514564487

The incidence and prevalence of psychiatric disorders in multiple sclerosis : A systematic review. / Marrie, Ruth Ann; Reingold, Stephen; Cohen, Jeffrey; Stuve, Olaf; Trojano, Maria; Sorensen, Per Soelberg; Cutter, Gary; Reider, Nadia.

In: Multiple Sclerosis, Vol. 21, No. 3, 16.03.2015, p. 305-317.

Research output: Contribution to journalArticle

Marrie, RA, Reingold, S, Cohen, J, Stuve, O, Trojano, M, Sorensen, PS, Cutter, G & Reider, N 2015, 'The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review', Multiple Sclerosis, vol. 21, no. 3, pp. 305-317. https://doi.org/10.1177/1352458514564487
Marrie, Ruth Ann ; Reingold, Stephen ; Cohen, Jeffrey ; Stuve, Olaf ; Trojano, Maria ; Sorensen, Per Soelberg ; Cutter, Gary ; Reider, Nadia. / The incidence and prevalence of psychiatric disorders in multiple sclerosis : A systematic review. In: Multiple Sclerosis. 2015 ; Vol. 21, No. 3. pp. 305-317.
@article{d154a6d8a9ae4221aa2c40602c1772fd,
title = "The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review",
abstract = "Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. Methods: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I2 statistic, and conducted meta-analyses. Results: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9{\%} (95{\%} CI: 8.76{\%}35.0{\%}), while it was 14.8{\%} for alcohol abuse, 5.83{\%} for bipolar disorder, 23.7{\%} (95{\%} CI: 17.4{\%}30.0{\%}) for depression, 2.5{\%} for substance abuse, and 4.3{\%} (95{\%} CI: 0{\%}10.3{\%}) for psychosis. Conclusion: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.",
keywords = "anxiety, bipolar disorder, comorbidity, depression, incidence, Multiple sclerosis, prevalence, psychosis, systematic review",
author = "Marrie, {Ruth Ann} and Stephen Reingold and Jeffrey Cohen and Olaf Stuve and Maria Trojano and Sorensen, {Per Soelberg} and Gary Cutter and Nadia Reider",
year = "2015",
month = "3",
day = "16",
doi = "10.1177/1352458514564487",
language = "English (US)",
volume = "21",
pages = "305--317",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - The incidence and prevalence of psychiatric disorders in multiple sclerosis

T2 - A systematic review

AU - Marrie, Ruth Ann

AU - Reingold, Stephen

AU - Cohen, Jeffrey

AU - Stuve, Olaf

AU - Trojano, Maria

AU - Sorensen, Per Soelberg

AU - Cutter, Gary

AU - Reider, Nadia

PY - 2015/3/16

Y1 - 2015/3/16

N2 - Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. Methods: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I2 statistic, and conducted meta-analyses. Results: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%10.3%) for psychosis. Conclusion: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.

AB - Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. Methods: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I2 statistic, and conducted meta-analyses. Results: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%10.3%) for psychosis. Conclusion: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.

KW - anxiety

KW - bipolar disorder

KW - comorbidity

KW - depression

KW - incidence

KW - Multiple sclerosis

KW - prevalence

KW - psychosis

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=84924803714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924803714&partnerID=8YFLogxK

U2 - 10.1177/1352458514564487

DO - 10.1177/1352458514564487

M3 - Article

C2 - 25583845

AN - SCOPUS:84924803714

VL - 21

SP - 305

EP - 317

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 3

ER -